ArticleCells2024

Pre-Clinical Assessment of SAR442257, a CD38/CD3xCD28 Trispecific T Cell Engager in Treatment of Relapsed/Refractory Multiple Myeloma.

Anna Luise Grab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.